MWI Veterinary Supply, Inc. - FORM 10-Q/A - July 20, 2011

Attached files

file filename
EX-32 - EXHIBIT 32 - MWI Veterinary Supply, Inc.exhibit32.htm
EX-31.1 - EXHIBIT 31.1 - MWI Veterinary Supply, Inc.exhibit31_1.htm
EX-31.2 - EXHIBIT 31.2 - MWI Veterinary Supply, Inc.exhibit31_2.htm
EX-10.1 - EXHIBIT 10.1 - MWI Veterinary Supply, Inc.exhibit10_1.htm

 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 10-Q/A
(Amendment No. 1)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2011
 
OR
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                      to                      
 
Commission File Number:  000-51468
MWI VETERINARY SUPPLY, INC.
(Exact name of registrant as specified in its Charter)
Delaware
  
02-0620757
(State of Incorporation)
  
(I.R.S. Employer Identification Number)
     
3041 W. Pasadena Dr.
    
Boise, ID
  
83705
(Address of principal executive offices)
  
(Zip Code)
     
(208) 955-8930
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   Yes o  No  o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
o        
  
Accelerated filer  
x
Non-accelerated filer
o  (Do not check if a smaller reporting company)
Smaller reporting company   
o

 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
 
The number of shares of the registrant’s common stock, $0.01 par value, outstanding as of April 29, 2011 was 12,551,647.
 


 
 
 
 


EXPLANATORY NOTE
 
MWI Veterinary Supply, Inc. (the “Company”) filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2011 with the Securities and Exchange Commission on May 5, 2011 (the “Form 10-Q”). The Company is filing this Amendment No. 1 to the Form 10-Q (the “Amendment”) solely for the purpose of re-filing Exhibit 10.1 in response to comments from the Securities and Exchange Commission provided in connection with a request for confidential treatment.  This Amendment amends and restates the exhibit index included in Part II, Item 6 of the Form 10-Q.
 
The Form 10-Q has not been updated other than for the change to Part II, Item 6 indicated above. No other items included in the Form 10-Q have been amended, and such items remain in effect as of the filing date of the Form 10-Q. This Amendment does not purport to provide an update or a discussion of any developments at the Company subsequent to the original filing date of the Form 10-Q.
 
In addition, this Amendment includes, as Exhibits 31.1, 31.2 and 32, new certifications by our principal executive officer and principal financial officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002.

 
 
 
 


PART II.  OTHER INFORMATION

ITEM 6.
EXHIBITS
10.1
  
2011 Livestock Products Distribution Agreement between MWI Veterinary Supply, Inc. and Pfizer, Inc. effective as of January 1, 2011 †
     
10.2
  
2011 Strategic Brands Distribution Agreement between MWI Veterinary Supply, Inc. and Pfizer, Inc. effective as of January 1, 2011 *†
     
15
  
Letter re: Unaudited Interim Financial Information *
     
31.1
  
Certification of CEO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2
  
Certification of CFO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32
 
 
  
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
 
* Previously filed.
† Certain portions of the exhibit have been omitted pursuant to a confidential treatment request submitted to and approved by the SEC.

 
 
 
 


SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
             
Date: July 20, 2011
      
MWI VETERINARY SUPPLY, INC.
             
       
By:
  
/s/ Mary Patricia B. Thompson
           
Mary Patricia B. Thompson
           
Senior Vice President of Finance and Administration, Chief Financial Officer
       


 
 
 
 

MWI Veterinary Supply, Inc. Reports